Induction of motor neurons from pluripotent stem cells
The present invention aims to provide a method of producing motor neurons/neurons that sufficiently reproduce intrinsic properties of motor neurons/neurons, especially of the motor neurons/neurons in patients, from pluripotent stem cells promptly and synchronically, and a pluripotent stem cell capable of differentiating into a neuron or a motor neuron promptly and synchronically after a drug treatment. A method of generating a motor neuron from a pluripotent stem cell, comprising the following steps in order from (1) to (2): (1) introducing one or more nucleic acids encoding Lhx3, Ngn2, and Isl1 into a pluripotent stem cell; and (2) maintaining expression of the Lhx3, Ngn2, and Isl1 for three days or more.
1. A method of generating a motor neuron from a pluripotent stem cell in vitro, comprising in order from (1) to (3):
(1) introducing a vector comprising an inducible promoter operably linked to Lhx3, Ngn2, and Isl1 genes into the pluripotent stem cell;
(2) inducing expression of the Lhx3, Ngn2, and Isl1 genes in the pluripotent stem cell from (1) in KSR media or N3 media containing a drug capable of inducing an activation of the promoter; and
(3) culturing the pluripotent stem cell from (2) and maintaining expression of the Lhx3, Ngn2, and Isl1 genes for three days or more in said cell, thereby producing a motor neuron.
2. The method according to claim 1 , wherein Lhx3, Ngn2, and Isl1 genes are polycistronically expressed from the one or more nucleic acids.
3. The method according to claim 1 , wherein expression of the Lhx3, Ngn2, and Isl1 genes is maintained for 7 days or more in step (2).
4. The method according to claim 1 , wherein said pluripotent stem cell is an induced pluripotent stem cell derived from a human.
5. The method according to claim 1 , wherein said pluripotent stem cell has one or more mutant SOD1 genes.
6. The method according to claim 1 , wherein in step (2), expression of the Lhx3, Ngn2, and Isl1 genes in the pluripotent stem cell from (1) is induced in N3 media containing the drug capable of inducing an activation of the promoter.
7. The method according to claim 1 , wherein in step (2), expression of the Lhx3, Ngn2, and Isl1 genes in the pluripotent stem cell from (1) is induced in KSR media containing the drug capable of inducing an activation of the promoter.